Connect your AI

Eli Lilly LLY Ireland — Non-Current Assets

Other financials

Income statement

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

Market cap$1.09T+56.4%

Enterprise value$1.12T+53.8%

P/E42.9×-7.3×

P/S15×+2.0×

Profitability

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Eli Lilly’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's ireland — non-current assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eli Lilly's ireland — non-current assets?: Eli Lilly (LLY) reported ireland — non-current assets of $4.32B in Q4 2025.
How has Eli Lilly's ireland — non-current assets changed year-over-year?: Eli Lilly's ireland — non-current assets increased by 34.8% year-over-year, from $3.21B to $4.32B.